Literature DB >> 6496856

The negative effect of splenectomy on the prognosis of gastric cancer.

S Suehiro, N Nagasue, Y Ogawa, Y Sasaki, S Hirose, H Yukaya.   

Abstract

During the 11 year period from 1970 through 1980, 103 patients underwent total gastrectomy for gastric cancer. Splenectomy was performed in 53 of the patients because of perioperative accidental injury or an operative finding of tumor metastasis to the lymph nodes or direct invasion to the splenic hilus. Retrospective comparisons were carried out among the 53 splenectomized and 50 nonsplenectomized patients in terms of the long-term survival rate and early and late complications. The two groups of patients were quite similar with regard to rates of curative resection and stages of disease. The 5 year cumulative survival rates overall and in the splenectomized and nonsplenectomized groups were 23.1, 21.8 and 23.8 percent, respectively. Splenectomy did not affect the prognosis of gastric cancer. In addition, there were no differences between the two groups in the incidences of early surgical complications and infectious disease of late onset. Our results suggest that, in the treatment of gastric cancer, splenectomy may not be avoided, either when the spleen is injured perioperatively or when cancer involvement is suspected in the splenic hilus.

Entities:  

Mesh:

Year:  1984        PMID: 6496856     DOI: 10.1016/0002-9610(84)90343-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  Two-color flow cytometric analysis of splenic lymphocyte subpopulations in patients with gastric cancer.

Authors:  M Takahashi; S Fujimoto; M Takai; K Ohno; F Endoh; Y Masuda; Y Masuda; G Obata
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  Spleen function in diseases.

Authors:  J Pereira; L E Hughes
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

3.  Monitoring immunocompetent cells in the peripheral blood of stomach cancer patients after splenectomy and gastrectomy.

Authors:  C Lersch; J Schreiner; N Demmel; C Hammer; J von Finckenstein; J Koller; P Dirschedl; F Krombach; B Günther; W Brendel
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

4.  Effect of arginase on splenic killer cell activity in patients with gastric cancer.

Authors:  C W Wu; C W Chi; C K Ho; S L Chien; W Y Liu; F K P'eng; S R Wang
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

5.  Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.

Authors:  S Saji; J Sakamoto; S Teramukai; K Kunieda; Y Sugiyama; Y Ohashi; H Nakazato
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

6.  Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.

Authors:  Robert C G Martin; David P Jaques; Murray F Brennan; Martin Karpeh
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

7.  Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis.

Authors:  Kun Yang; Xin-Zu Chen; Jian-Kun Hu; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

8.  Preservation of the spleen improves survival after radical surgery for gastric cancer.

Authors:  J P Griffith; H M Sue-Ling; I Martin; M F Dixon; M J McMahon; A T Axon; D Johnston
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

9.  Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma.

Authors:  E Otsuji; T Yamaguchi; K Sawai; K Okamoto; T Takahashi
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.